accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001193125-26-343482 | 1719714 | Mereo BioPharma Group plc | MREO | 2026-08-11 | 8-K | orphan | false | mreo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1719714/000119312526343482/mreo-ex99_1.htm |
0001193125-26-344878 | 1842295 | Maze Therapeutics, Inc. | MAZE | 2026-08-11 | 8-K | topline | false | maze-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1842295/000119312526344878/maze-ex99_1.htm |
0001193125-26-343479 | 1691082 | LB PHARMACEUTICALS INC | LBRX | 2026-08-11 | 8-K | topline | false | d303033dex991.htm | https://www.sec.gov/Archives/edgar/data/1691082/000119312526343479/d303033dex991.htm |
0001193125-26-344572 | 1994702 | Kyverna Therapeutics, Inc. | KYTX | 2026-08-11 | 8-K | topline | false | kytx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1994702/000119312526344572/kytx-ex99_1.htm |
0001628280-26-055477 | 1567892 | Keenova Therapeutics plc | null | 2026-08-11 | 8-K | topline | false | a20260630keenovaex991q2202.htm | https://www.sec.gov/Archives/edgar/data/1567892/000162828026055477/a20260630keenovaex991q2202.htm |
0001193125-26-343395 | 2123613 | Kardigan, Inc. | KARD | 2026-08-11 | 8-K | topline | false | ck0002123613-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2123613/000119312526343395/ck0002123613-ex99_1.htm |
0001193125-26-344623 | 1750149 | Inhibikase Therapeutics, Inc. | IKT | 2026-08-11 | 8-K | topline | false | d134059dex991.htm | https://www.sec.gov/Archives/edgar/data/1750149/000119312526344623/d134059dex991.htm |
0001193125-26-344623 | 1750149 | Inhibikase Therapeutics, Inc. | IKT | 2026-08-11 | 8-K | orphan | false | d134059dex991.htm | https://www.sec.gov/Archives/edgar/data/1750149/000119312526344623/d134059dex991.htm |
0001193125-26-344577 | 1472012 | Immunome Inc. | IMNM | 2026-08-11 | 8-K | endpoint_met | false | imnm-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1472012/000119312526344577/imnm-ex99_1.htm |
0001193125-26-344577 | 1472012 | Immunome Inc. | IMNM | 2026-08-11 | 8-K | pdufa | false | imnm-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1472012/000119312526344577/imnm-ex99_1.htm |
0001683168-26-006203 | 736012 | INTRUSION INC | INTZ | 2026-08-11 | 8-K | topline | false | intrusion_ex9901.htm | https://www.sec.gov/Archives/edgar/data/736012/000168316826006203/intrusion_ex9901.htm |
0001193805-26-001071 | 1280776 | IMMUNIC, INC. | IMUX | 2026-08-11 | 8-K | topline | false | e665684_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1280776/000119380526001071/e665684_ex99-2.htm |
0001193125-26-343421 | 2114044 | Hemab Therapeutics Holdings, Inc. | COAG | 2026-08-11 | 8-K | breakthrough | false | d180684dex991.htm | https://www.sec.gov/Archives/edgar/data/2114044/000119312526343421/d180684dex991.htm |
0001193125-26-343421 | 2114044 | Hemab Therapeutics Holdings, Inc. | COAG | 2026-08-11 | 8-K | fast_track | false | d180684dex991.htm | https://www.sec.gov/Archives/edgar/data/2114044/000119312526343421/d180684dex991.htm |
0001193125-26-343421 | 2114044 | Hemab Therapeutics Holdings, Inc. | COAG | 2026-08-11 | 8-K | orphan | false | d180684dex991.htm | https://www.sec.gov/Archives/edgar/data/2114044/000119312526343421/d180684dex991.htm |
0001104659-26-094041 | 1819411 | Gain Therapeutics, Inc. | GANX | 2026-08-11 | 8-K | ind | false | ganx-20260811xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1819411/000110465926094041/ganx-20260811xex99d1.htm |
0001193125-26-345032 | 1035354 | Eloxx Pharmaceuticals, Inc. | ELOX | 2026-08-11 | 8-K | topline | false | d167833dex991.htm | https://www.sec.gov/Archives/edgar/data/1035354/000119312526345032/d167833dex991.htm |
0001193125-26-345032 | 1035354 | Eloxx Pharmaceuticals, Inc. | ELOX | 2026-08-11 | 8-K | orphan | false | d167833dex991.htm | https://www.sec.gov/Archives/edgar/data/1035354/000119312526345032/d167833dex991.htm |
0001193125-26-345032 | 1035354 | Eloxx Pharmaceuticals, Inc. | ELOX | 2026-08-11 | 8-K | ind | false | d167833dex991.htm | https://www.sec.gov/Archives/edgar/data/1035354/000119312526345032/d167833dex991.htm |
0001104659-26-094134 | 1041934 | EDAP TMS SA | FOCL | 2026-08-11 | 8-K | interim | false | tm2622525d2_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1041934/000110465926094134/tm2622525d2_ex99-2.htm |
0001193125-26-343473 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-08-11 | 8-K | topline | false | coya-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526343473/coya-ex99_1.htm |
0001193125-26-343473 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-08-11 | 8-K | fast_track | false | coya-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526343473/coya-ex99_1.htm |
0001628280-26-055500 | 2023658 | Bicara Therapeutics Inc. | BCAX | 2026-08-11 | 8-K | topline | false | projectwaystar-2q26earning.htm | https://www.sec.gov/Archives/edgar/data/2023658/000162828026055500/projectwaystar-2q26earning.htm |
0001628280-26-055500 | 2023658 | Bicara Therapeutics Inc. | BCAX | 2026-08-11 | 8-K | interim | false | projectwaystar-2q26earning.htm | https://www.sec.gov/Archives/edgar/data/2023658/000162828026055500/projectwaystar-2q26earning.htm |
0001193125-26-343408 | 1501796 | Aura Biosciences, Inc. | AURA | 2026-08-11 | 8-K | topline | false | aura-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1501796/000119312526343408/aura-ex99_1.htm |
0001398733-26-000041 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-08-11 | 8-K | crl | true | q22026-ex991earningsrelease.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000041/q22026-ex991earningsrelease.htm |
0001193125-26-344978 | 1774857 | Aardvark Therapeutics, Inc. | AARD | 2026-08-11 | 8-K | clinical_hold | true | ck0001774857-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1774857/000119312526344978/ck0001774857-ex99_1.htm |
0001193125-26-344978 | 1774857 | Aardvark Therapeutics, Inc. | AARD | 2026-08-11 | 8-K | ind | false | ck0001774857-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1774857/000119312526344978/ck0001774857-ex99_1.htm |
0001731122-26-001042 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-08-11 | 8-K | orphan | false | e7842_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/e7842_ex99-1.htm |
0001731122-26-001042 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-08-11 | 8-K | ind | false | e7842_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001042/e7842_ex99-1.htm |
0001193125-26-344549 | 1880438 | AN2 Therapeutics, Inc. | ANTX | 2026-08-11 | 8-K | topline | false | antx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1880438/000119312526344549/antx-ex99_1.htm |
0001193125-26-344571 | 949858 | ACHIEVE LIFE SCIENCES, INC. | ACHV | 2026-08-11 | 8-K | crl | true | achv-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/949858/000119312526344571/achv-ex99_1.htm |
0001193125-26-344571 | 949858 | ACHIEVE LIFE SCIENCES, INC. | ACHV | 2026-08-11 | 8-K | breakthrough | false | achv-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/949858/000119312526344571/achv-ex99_1.htm |
0001193125-26-342335 | 1831828 | Vera Therapeutics, Inc. | VERA | 2026-08-10 | 8-K | topline | false | vera-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1831828/000119312526342335/vera-ex99_1.htm |
0001193125-26-341187 | 863894 | VERU INC. | VERU | 2026-08-10 | 8-K | topline | false | d123580dex991.htm | https://www.sec.gov/Archives/edgar/data/863894/000119312526341187/d123580dex991.htm |
0001193125-26-341187 | 863894 | VERU INC. | VERU | 2026-08-10 | 8-K | interim | false | d123580dex991.htm | https://www.sec.gov/Archives/edgar/data/863894/000119312526341187/d123580dex991.htm |
0001493152-26-036740 | 1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | 2026-08-10 | 8-K | topline | false | ex99-01.htm | https://www.sec.gov/Archives/edgar/data/1430306/000149315226036740/ex99-01.htm |
0001493152-26-036740 | 1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | 2026-08-10 | 8-K | breakthrough | false | ex99-01.htm | https://www.sec.gov/Archives/edgar/data/1430306/000149315226036740/ex99-01.htm |
0001493152-26-036742 | 1971532 | Telomir Pharmaceuticals, Inc. | TELO | 2026-08-10 | 8-K | ind | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1971532/000149315226036742/ex99-1.htm |
0001193125-26-341236 | 34956 | TENAX THERAPEUTICS, INC. | TENX | 2026-08-10 | 8-K | topline | false | d115761dex992.htm | https://www.sec.gov/Archives/edgar/data/34956/000119312526341236/d115761dex992.htm |
0001193125-26-341236 | 34956 | TENAX THERAPEUTICS, INC. | TENX | 2026-08-10 | 8-K | endpoint_missed | true | d115761dex992.htm | https://www.sec.gov/Archives/edgar/data/34956/000119312526341236/d115761dex992.htm |
0001193125-26-341230 | 2036042 | Sionna Therapeutics, Inc. | SION | 2026-08-10 | 8-K | topline | false | d135438dex991.htm | https://www.sec.gov/Archives/edgar/data/2036042/000119312526341230/d135438dex991.htm |
0001193125-26-341293 | 1479615 | Silence Therapeutics plc | null | 2026-08-10 | 8-K | topline | false | d12947dex991.htm | https://www.sec.gov/Archives/edgar/data/1479615/000119312526341293/d12947dex991.htm |
0001193125-26-341293 | 1479615 | Silence Therapeutics plc | null | 2026-08-10 | 8-K | endpoint_met | false | d12947dex991.htm | https://www.sec.gov/Archives/edgar/data/1479615/000119312526341293/d12947dex991.htm |
0001193125-26-342371 | 1770121 | Sana Biotechnology, Inc. | SANA | 2026-08-10 | 8-K | ind | false | sana-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1770121/000119312526342371/sana-ex99_1.htm |
0001193125-26-342397 | 1850270 | PROKIDNEY CORP. | PROK | 2026-08-10 | 8-K | topline | false | prok-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1850270/000119312526342397/prok-ex99_1.htm |
0001193125-26-342334 | 1750284 | Olema Pharmaceuticals, Inc. | OLMA | 2026-08-10 | 8-K | topline | false | olma-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1750284/000119312526342334/olma-ex99_1.htm |
0001193125-26-342334 | 1750284 | Olema Pharmaceuticals, Inc. | OLMA | 2026-08-10 | 8-K | fast_track | false | olma-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1750284/000119312526342334/olma-ex99_1.htm |
0001829126-26-008543 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-10 | 8-K | topline | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008543/neonctechnologies_ex99-1.htm |
0001213900-26-086939 | 1821586 | MoonLake Immunotherapeutics | MLTX | 2026-08-10 | 8-K | topline | false | ea030119101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1821586/000121390026086939/ea030119101ex99-1.htm |
0001213900-26-086939 | 1821586 | MoonLake Immunotherapeutics | MLTX | 2026-08-10 | 8-K | endpoint_met | false | ea030119101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1821586/000121390026086939/ea030119101ex99-1.htm |
0001213900-26-086939 | 1821586 | MoonLake Immunotherapeutics | MLTX | 2026-08-10 | 8-K | interim | false | ea030119101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1821586/000121390026086939/ea030119101ex99-1.htm |
0001213900-26-086939 | 1821586 | MoonLake Immunotherapeutics | MLTX | 2026-08-10 | 8-K | pdufa | false | ea030119101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1821586/000121390026086939/ea030119101ex99-1.htm |
0001193125-26-342667 | 1232524 | Jazz Pharmaceuticals plc | JAZZ | 2026-08-10 | 8-K | clinical_hold | true | d151973dex21.htm | https://www.sec.gov/Archives/edgar/data/1232524/000119312526342667/d151973dex21.htm |
0001193125-26-342667 | 1232524 | Jazz Pharmaceuticals plc | JAZZ | 2026-08-10 | 8-K | ind | false | d151973dex21.htm | https://www.sec.gov/Archives/edgar/data/1232524/000119312526342667/d151973dex21.htm |
0001493152-26-036865 | 1360214 | HARROW, INC. | HROW | 2026-08-10 | 8-K | topline | false | ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1360214/000149315226036865/ex99-2.htm |
0001193125-26-342343 | 1572616 | FRACTYL HEALTH, INC. | GUTS | 2026-08-10 | 8-K | topline | false | guts-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1572616/000119312526342343/guts-ex99_1.htm |
0001193125-26-342336 | 1177648 | ENANTA PHARMACEUTICALS INC | ENTA | 2026-08-10 | 8-K | topline | false | enta-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1177648/000119312526342336/enta-ex99_1.htm |
0001193125-26-342336 | 1177648 | ENANTA PHARMACEUTICALS INC | ENTA | 2026-08-10 | 8-K | fast_track | false | enta-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1177648/000119312526342336/enta-ex99_1.htm |
0001437749-26-026790 | 1401040 | DiaMedica Therapeutics Inc. | DMAC | 2026-08-10 | 8-K | topline | false | ex_1001907.htm | https://www.sec.gov/Archives/edgar/data/1401040/000143774926026790/ex_1001907.htm |
0001437749-26-026790 | 1401040 | DiaMedica Therapeutics Inc. | DMAC | 2026-08-10 | 8-K | interim | false | ex_1001907.htm | https://www.sec.gov/Archives/edgar/data/1401040/000143774926026790/ex_1001907.htm |
0001437749-26-026790 | 1401040 | DiaMedica Therapeutics Inc. | DMAC | 2026-08-10 | 8-K | ind | false | ex_1001907.htm | https://www.sec.gov/Archives/edgar/data/1401040/000143774926026790/ex_1001907.htm |
0001193125-26-341315 | 1622229 | Cogent Biosciences, Inc. | COGT | 2026-08-10 | 8-K | pdufa | false | cogt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1622229/000119312526341315/cogt-ex99_1.htm |
0001437749-26-026653 | 1822791 | Clene Inc. | CLNN | 2026-08-10 | 8-K | endpoint_met | false | ex_1000745.htm | https://www.sec.gov/Archives/edgar/data/1822791/000143774926026653/ex_1000745.htm |
0001437749-26-026771 | 1053691 | CervoMed Inc. | CRVO | 2026-08-10 | 8-K | topline | false | ex_1002031.htm | https://www.sec.gov/Archives/edgar/data/1053691/000143774926026771/ex_1002031.htm |
0001743881-26-000026 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-08-10 | 8-K | topline | false | bbio-20260630xex991.htm | https://www.sec.gov/Archives/edgar/data/1743881/000174388126000026/bbio-20260630xex991.htm |
0001743881-26-000026 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-08-10 | 8-K | interim | false | bbio-20260630xex991.htm | https://www.sec.gov/Archives/edgar/data/1743881/000174388126000026/bbio-20260630xex991.htm |
0001743881-26-000026 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-08-10 | 8-K | orphan | false | bbio-20260630xex991.htm | https://www.sec.gov/Archives/edgar/data/1743881/000174388126000026/bbio-20260630xex991.htm |
0001743881-26-000026 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-08-10 | 8-K | pdufa | false | bbio-20260630xex991.htm | https://www.sec.gov/Archives/edgar/data/1743881/000174388126000026/bbio-20260630xex991.htm |
0001935979-26-000067 | 1935979 | Biohaven Ltd. | BHVN | 2026-08-10 | 8-K | topline | false | a2026q2bhvnearningsprex991.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000067/a2026q2bhvnearningsprex991.htm |
0001193125-26-341206 | 1579428 | Axsome Therapeutics, Inc. | AXSM | 2026-08-10 | 8-K | topline | false | axsm-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1579428/000119312526341206/axsm-ex99_2.htm |
0001193125-26-341206 | 1579428 | Axsome Therapeutics, Inc. | AXSM | 2026-08-10 | 8-K | orphan | false | axsm-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1579428/000119312526341206/axsm-ex99_1.htm |
0001193125-26-341206 | 1579428 | Axsome Therapeutics, Inc. | AXSM | 2026-08-10 | 8-K | pdufa | false | axsm-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1579428/000119312526341206/axsm-ex99_1.htm |
0001398733-26-000035 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-08-10 | 8-K | topline | false | humanfactorspkstudyresul.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000035/humanfactorspkstudyresul.htm |
0001398733-26-000035 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-08-10 | 8-K | crl | true | humanfactorspkstudyresul.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000035/humanfactorspkstudyresul.htm |
0001193125-26-341239 | 1974640 | Apogee Therapeutics, Inc. | APGE | 2026-08-10 | 8-K | endpoint_met | false | apge-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1974640/000119312526341239/apge-ex99_1.htm |
0001703057-26-000053 | 1703057 | AbCellera Biologics Inc. | ABCL | 2026-08-10 | 8-K | topline | false | abcl-20260810.htm | https://www.sec.gov/Archives/edgar/data/1703057/000170305726000053/abcl-20260810.htm |
0001104659-26-093353 | 1847367 | ALUMIS INC. | ALMS | 2026-08-10 | 8-K | topline | false | tm2622655d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1847367/000110465926093353/tm2622655d1_ex99-1.htm |
0001339970-26-000051 | 1339970 | aTYR PHARMA INC | ATYR | 2026-08-07 | 8-K | topline | false | atyr-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1339970/000133997026000051/atyr-ex99_1.htm |
0001104659-26-092216 | 1526119 | Verastem, Inc. | VSTM | 2026-08-07 | 8-K | topline | false | tm2622452d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926092216/tm2622452d1_ex99-1.htm |
0001104659-26-092216 | 1526119 | Verastem, Inc. | VSTM | 2026-08-07 | 8-K | clinical_hold | true | tm2622452d1_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926092216/tm2622452d1_ex10-1.htm |
0001104659-26-092216 | 1526119 | Verastem, Inc. | VSTM | 2026-08-07 | 8-K | fast_track | false | tm2622452d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926092216/tm2622452d1_ex99-1.htm |
0001104659-26-092246 | 1737953 | Replimune Group, Inc. | REPL | 2026-08-07 | 8-K | pdufa | false | tm2622487d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1737953/000110465926092246/tm2622487d1_ex99-2.htm |
0001193125-26-339147 | 1598646 | Minerva Neurosciences, Inc. | NERV | 2026-08-07 | 8-K | topline | false | d22348dex991.htm | https://www.sec.gov/Archives/edgar/data/1598646/000119312526339147/d22348dex991.htm |
0001372514-26-000075 | 1372514 | KIORA PHARMACEUTICALS INC | null | 2026-08-07 | 8-K | topline | false | ex991-pressreleasejune3020.htm | https://www.sec.gov/Archives/edgar/data/1372514/000137251426000075/ex991-pressreleasejune3020.htm |
0001193125-26-339223 | 1124105 | GYRE THERAPEUTICS, INC. | GYRE | 2026-08-07 | 8-K | breakthrough | false | gyre-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1124105/000119312526339223/gyre-ex99_1.htm |
0001178913-26-003946 | 1638097 | Entera Bio Ltd. | ENTX | 2026-08-07 | 8-K | topline | false | exhibit_99-1.htm | https://www.sec.gov/Archives/edgar/data/1638097/000117891326003946/exhibit_99-1.htm |
0001410098-26-000044 | 1410098 | CorMedix Inc. | CRMD | 2026-08-07 | 8-K | crl | true | crmd-8xkxaugust72026xex991.htm | https://www.sec.gov/Archives/edgar/data/1410098/000141009826000044/crmd-8xkxaugust72026xex991.htm |
0001703057-26-000049 | 1703057 | AbCellera Biologics Inc. | ABCL | 2026-08-07 | 8-K | topline | false | abcellera-toxannouncexto.htm | https://www.sec.gov/Archives/edgar/data/1703057/000170305726000049/abcellera-toxannouncexto.htm |
0001193125-26-339292 | 1488039 | ATOSSA THERAPEUTICS, INC. | ATOS | 2026-08-07 | 8-K | orphan | false | atos-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1488039/000119312526339292/atos-ex99_1.htm |
0001023024-26-000068 | 1023024 | ANI PHARMACEUTICALS INC | ANIP | 2026-08-07 | 8-K | topline | false | anip-20260807xexx991.htm | https://www.sec.gov/Archives/edgar/data/1023024/000102302426000068/anip-20260807xexx991.htm |
0001641489-26-000029 | 1641489 | vTv Therapeutics Inc. | VTVT | 2026-08-06 | 8-K | topline | false | vtvt-20260630xexx991pressr.htm | https://www.sec.gov/Archives/edgar/data/1641489/000164148926000029/vtvt-20260630xexx991pressr.htm |
0001641489-26-000029 | 1641489 | vTv Therapeutics Inc. | VTVT | 2026-08-06 | 8-K | breakthrough | false | vtvt-20260630xexx991pressr.htm | https://www.sec.gov/Archives/edgar/data/1641489/000164148926000029/vtvt-20260630xexx991pressr.htm |
0001937653-26-000046 | 1937653 | Zymeworks Inc. | ZYME | 2026-08-06 | 8-K | topline | false | ex991q22026_earningsxrelea.htm | https://www.sec.gov/Archives/edgar/data/1937653/000193765326000046/ex991q22026_earningsxrelea.htm |
0001937653-26-000046 | 1937653 | Zymeworks Inc. | ZYME | 2026-08-06 | 8-K | breakthrough | false | ex991q22026_earningsxrelea.htm | https://www.sec.gov/Archives/edgar/data/1937653/000193765326000046/ex991q22026_earningsxrelea.htm |
0001937653-26-000046 | 1937653 | Zymeworks Inc. | ZYME | 2026-08-06 | 8-K | pdufa | false | ex991q22026_earningsxrelea.htm | https://www.sec.gov/Archives/edgar/data/1937653/000193765326000046/ex991q22026_earningsxrelea.htm |
0001725160-26-000061 | 1725160 | Zentalis Pharmaceuticals, Inc. | ZNTL | 2026-08-06 | 8-K | interim | false | zntlq22026pressrelease.htm | https://www.sec.gov/Archives/edgar/data/1725160/000172516026000061/zntlq22026pressrelease.htm |
0001725160-26-000061 | 1725160 | Zentalis Pharmaceuticals, Inc. | ZNTL | 2026-08-06 | 8-K | fast_track | false | zntlq22026corporatedeckf.htm | https://www.sec.gov/Archives/edgar/data/1725160/000172516026000061/zntlq22026corporatedeckf.htm |
0001628280-26-053791 | 1704292 | Zai Lab Ltd | ZLAB | 2026-08-06 | 8-K | topline | false | zlab-202686x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1704292/000162828026053791/zlab-202686x8kex991.htm |
0001628280-26-053791 | 1704292 | Zai Lab Ltd | ZLAB | 2026-08-06 | 8-K | interim | false | zlab-202686x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1704292/000162828026053791/zlab-202686x8kex991.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.